Tower Research Capital (TRC)’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.5K | Buy |
27,458
+20,244
| +281% | +$39.5K | ﹤0.01% | 2918 |
|
|
2025
Q1 | $12.7K | Buy |
7,214
+2,908
| +68% | +$5.12K | ﹤0.01% | 3428 |
|
|
2024
Q4 | $11.5K | Sell |
4,306
-3,992
| -48% | -$10.6K | ﹤0.01% | 3713 |
|
|
2024
Q3 | $19K | Sell |
8,298
-11,575
| -58% | -$26.5K | ﹤0.01% | 3265 |
|
|
2024
Q2 | $58K | Buy |
19,873
+3,159
| +19% | +$9.22K | ﹤0.01% | 2983 |
|
|
2024
Q1 | $60.8K | Buy |
16,714
+8,139
| +95% | +$29.6K | ﹤0.01% | 2144 |
|
|
2023
Q4 | $12.9K | Sell |
8,575
-3,641
| -30% | -$5.5K | ﹤0.01% | 3998 |
|
|
2023
Q3 | $16.4K | Buy |
12,216
+8,856
| +264% | +$11.9K | ﹤0.01% | 3562 |
|
|
2023
Q2 | $6.05K | Sell |
3,360
-30,910
| -90% | -$55.6K | ﹤0.01% | 4722 |
|
|
2023
Q1 | $57K | Buy |
34,270
+24,315
| +244% | +$40.4K | ﹤0.01% | 2378 |
|
|
2022
Q4 | $19K | Buy |
9,955
+1,199
| +14% | +$2.29K | ﹤0.01% | 3180 |
|
|
2022
Q3 | $20K | Sell |
8,756
-646
| -7% | -$1.48K | ﹤0.01% | 3938 |
|
|
2022
Q2 | $30K | Buy |
9,402
+8,164
| +659% | +$26.1K | ﹤0.01% | 3382 |
|
|
2022
Q1 | $7K | Sell |
1,238
-1,350
| -52% | -$7.63K | ﹤0.01% | 4742 |
|
|
2021
Q4 | $22K | Sell |
2,588
-1,110
| -30% | -$9.44K | ﹤0.01% | 3564 |
|
|
2021
Q3 | $37K | Buy |
3,698
+2,913
| +371% | +$29.1K | ﹤0.01% | 3200 |
|
|
2021
Q2 | $7K | Buy |
785
+110
| +16% | +$981 | ﹤0.01% | 4561 |
|
|
2021
Q1 | $7K | Sell |
675
-641
| -49% | -$6.65K | ﹤0.01% | 4542 |
|
|
2020
Q4 | $15K | Buy |
+1,316
| New | +$15K | ﹤0.01% | 4050 |
|